Magnetic field maps with NV sensors for non-invasive heart measurements
Official title: Magnetic Field Maps With NV Application Kit MCG
Run by Robert Bosch GmbH · NCT07908173 · Data updated 2026-11-12
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Robert Bosch GmbH Industry-sponsored |
| Locations | 1 site (Renningen) |
| Status | Recruiting |
| Started | October 23, 2026 |
| Main results expected | February 28, 2028 |
| Study ends | May 30, 2028 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07908173 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18 years or older who are employees of Bosch entities and can consent and adhere to procedures.
✕Probably not a fit
Individuals with known cardiac, neurological, or psychiatric disease, or those unable to remain still, may not benefit from this exploratory study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center exploratory feasibility study evaluating the use of nitrogen-vacancy diamond sensors to perform magnetocardiography. The goal is to determine if highly sensitive NV sensors can reliably detect the heart's weak magnetic fields and reconstruct meaningful signals for potential future cardiac diagnostics. Measurement is performed contactlessly with participants in a supine position, under an observational protocol. Eligible adults must be healthy and able to provide consent. The study is sponsored by Bosch Quantum Sensing GmbH with Robert Bosch GmbH as a collaborator and is located at Renningen, Germany.
Why it matters
Potential benefit: If successful, the approach could lead to new, non-invasive cardiac monitoring options based on diamond-based magnetometry.
How similar studies have gone: Prior magnetometry research has shown feasibility in sensing cardiac magnetic fields with other sensors, supporting exploration of NV-based approaches.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years.\| * Employee of Robert Bosch GmbH or Bosch Quantum Sensing GmbH.\| * Able to provide written informed consent.\| * Able to comply with study procedures.\| * No acute physical or mental impairment.\| * No known cardiac disease.\| * Legally competent and capable of self-care.\| Exclusion Criteria: * Pregnancy\| * Known cardiac, neurological, or psychiatric disease.\| * Claustrophobia or agoraphobia.\| * Known cardiac arrhythmias.\| * Metallic implants, metallic prostheses, or cardiac pacemaker.\| * Inability to remain still in the supine position for several minutes.\| * Body weight \>99 kg.\| * Withdrawal of informed consent.\|
Where it's running
-
Robert Bosch GmbH Zentrum für Forschung und Vorausentwicklung
Renningen, Germany Recruiting
Study contacts
- Study coordinator: Eckhard Wehrse, MD
- Email: eckhard.wehrse@de.bosch.com
- Phone: +4971181129440
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Oura Ring validation for sleep using gold-standard sleep tests
This study tests how well the Oura Ring matches the gold-standard sleep test ( PSG ) in healthy adults and people with sleep apnea.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Cognitive Tasks and Models in a Large Online Sample
This study tests cognitive tasks and computational models in a large online group to see if these tools can help predict symptoms like hallucinations and delusions in the general population.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
-
A safe, carefully dosed test of TBD11 in healthy adults
This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.